health
April 29, 2026
US National Academy of Sciences withdrew historic study on pancreatic cancer by researcher Mariano Barbacid
The journal of the United States National Academy of Sciences PNAS withdrew the study led by researcher Mariano Barbacid, which managed to elimi...
TL;DR
- PNAS retracted a study on pancreatic cancer led by Mariano Barbacid.
- The retraction was due to a relevant conflict of interest not disclosed during submission.
- Barbacid and two co-authors have financial interests in Vega Oncotargets.
- The study showed a triple therapy achieved significant and lasting tumor regression in mice without significant toxicities.
- The therapy targeted KRAS, EGFR, and STAT3, key components in pancreatic adenocarcinoma.